688809-70-3

Upstream product

• 38580-68-6 4-hydroxymethyl-cyclohexanone 
• 18162-48-6 tert-butyldimethylsilyl chloride 

Downstream Products

• 90084-09-6 4-(((tert-butyldimethylsilyl)oxy)methyl)cyclohex-2-enone 
• 849676-42-2 (E)-3-(4-Methoxy-phenyl)-acrylic acid (1R,2S,3S,4S)-3-((E)-1,5-dimethyl-hex-1-enyl)-4-hydroxymethyl-2-methoxy-cyclohexyl ester 
• 849676-34-2 3(R)-4(S)-3-(1,5-dimethyl-hex-1-enyl)-4-(tert-butyl-dimethyl-silanyloxymethyl)-1-triethylsilanyloxy-cyclohexene 
• 849676-35-3 2(S)-3(S)-4(S)-3-(1,5-dimethyl-hex-1-enyl)-2-hydroxy-4-(tert-butyl-dimethyl-silanyloxymethyl)-cyclohexanone 
• 849676-41-1 1(R)-2(S)-3(S)-4(S)-3-(1,5-dimethyl-hex-1-enyl)-4-(tert-butyl-dimethyl-silanyloxymethyl)-2-methoxy-cyclohexanol 
• 849676-36-4 2(S)-3(S)-4(S)-3-(1,5-dimethyl-hex-1-enyl)-4-(tert-butyl-dimethyl-silanyloxymethyl)-2-methoxy-cyclohexanone 
• 849676-39-7 2(S)-3(S)-4(S)-3-(1,5-dimethyl-hex-1-enyl)-2-methoxy-4-(2,2,2-trifluoro-acetyl)-cyclohexanone 
• 849676-37-5 2(S)-3(S)-4(S)-3-(1,5-dimethyl-hex-1-enyl)-4-hydroxymethyl-2-methoxy-cyclohexanone 
• 872603-31-1 2(S)-3(S)-4(S)-3-(1,5-dimethyl-hex-1-enyl)-2-methoxy-4-(1-hydroxy-ethyl)-cyclohexanone 
• 849676-38-6 1(S)-2(S)-3(S)-2-(1,5-dimethyl-hex-1-enyl)-3-methoxy-4-oxo-cyclohexanecarbaldehyde 
• 849676-33-1 4(S)-4-(tert-butyl-dimethyl-silanyloxymethyl)-cyclohex-2-enone 

Relevant academic research and scientific papers

BRIDGED COMPOUNDS AS HIV INTEGRASE INHIBITORS

Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: the asterisk * in Q denotes the point of attachment to the rest of the compound; and n, L1, L2, X1, X2, χ3, Y, Z, R1, Rs

Novel Angiogenesis inhibitors and pharmaceutical/cosmetic applications thereof

Novel derivatives of fumagalone have the general formula (I): and are useful angiogenes is inhibitors; these can be formulated into pharmaceutical compositions suited for human or veterinary medicine, or can be formulated into cosmetic compositions.

Enantioselective approaches to potential MetAP-2 reversible inhibitors

(Chemical Equation Presented) Enantioselective deprotonation of 4-substituted cyclohexanones and highly stereoselective conjugate addition of higher order mixed cuprates were the key steps in a concise synthesis of fumagalone-related molecules. The origin

NOVEL QUINOXALINE DERIVATIVES

A quinoxalinone derivative of the formula (I): or a pharmaceutically acceptable salt or ester thereof, wherein; ???X is NH, S or the like; ???Y is O or the like; ???the partial structure is, for example, the formula: ???B1, B2, ....., Bn-1 and Bn, (in which n is 4 , 5 or 6) are each independently CH, N or the like; ???B'1, B'2, ....., B'n-1 and B'n (in which n is 4, 5 or 6) are each independently hydrogen or the like; and ???R is hydrogen, lower alkyl or the like.